Fundraising FoxArtis Ventures — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
AbbVie develops and sells biopharmaceutical therapies across immunology, neuroscience, oncology, and aesthetics, addressing autoimmune diseases, neurologic conditions, blood cancers, and cosmetic applications through products like Skyrizi, Rinvoq, Humira, Vraylar, Imbruvica, and Botox.
BiotechNorth Chicago, US
Thomas A. Hurwich(Executive Officer)Timothy J. Richmond(Executive Officer)Henry Gosebruch(Executive Officer)inAzita Saleki-Gerhardt(Executive Officer)inMichael E. Severino(Executive Officer)William Chase(Executive Officer)
PartnerStuart Peterson· quoted
Co-investorsFounders Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.